Merck & Company Hold Rating: Promising Drug Developments Amid Uncertain Financial Outlook
Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...
Bank of America Securities Remains a Buy on Merck & Company (MRK)
Bank of America Securities analyst Tim Anderson reiterated a Buy rating on Merck & Company (MRK – Research Report) today and set a price ...
FiercePharma18d
JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...
BBC24d
HS2 construction to close bypass for weeks
The A46 Kenilworth Bypass in Warwickshire will shut to allow a 14,500-tonne box structure, which will carry the railway underneath, to be moved into place. The structure is currently being built ...
BioSpace27d
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland. Facing increasing global pressure, WuXi ...